MX365051B - Nuevos compuestos hidrosolubles derivados del bencimidazol, utiles para el tratamiento de la fasciolosis. - Google Patents

Nuevos compuestos hidrosolubles derivados del bencimidazol, utiles para el tratamiento de la fasciolosis.

Info

Publication number
MX365051B
MX365051B MX2014014417A MX2014014417A MX365051B MX 365051 B MX365051 B MX 365051B MX 2014014417 A MX2014014417 A MX 2014014417A MX 2014014417 A MX2014014417 A MX 2014014417A MX 365051 B MX365051 B MX 365051B
Authority
MX
Mexico
Prior art keywords
compounds derived
fasciolosis
treating
benzimidazole
hydrosoluble compounds
Prior art date
Application number
MX2014014417A
Other languages
English (en)
Other versions
MX2014014417A (es
Inventor
Castillo Bocanegra Rafael
Angel Flores Ramos Miguel
Alicia Hernández Campos María
Froylán Ibarra Velarde Osvaldo
Yolanda Vera Montenegro Remedios
Original Assignee
Univ Mexico Nac Autonoma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=56074744&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX365051(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Mexico Nac Autonoma filed Critical Univ Mexico Nac Autonoma
Priority to MX2014014417A priority Critical patent/MX365051B/es
Priority to PE2017000898A priority patent/PE20171112A1/es
Priority to PCT/MX2015/000154 priority patent/WO2016085319A1/es
Priority to US15/529,218 priority patent/US10239842B2/en
Priority to BR112017010938-7A priority patent/BR112017010938B1/pt
Publication of MX2014014417A publication Critical patent/MX2014014417A/es
Priority to CL2017001320A priority patent/CL2017001320A1/es
Priority to CONC2017/0005118A priority patent/CO2017005118A2/es
Publication of MX365051B publication Critical patent/MX365051B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/28—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6503—Five-membered rings
    • C07F9/6506—Five-membered rings having the nitrogen atoms in positions 1 and 3
    • C07F9/65068—Five-membered rings having the nitrogen atoms in positions 1 and 3 condensed with carbocyclic rings or carbocyclic ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La presente invención se refiere a compuestos hidrosolubles derivados del bencimidazol representados por la fórmula general I: (ver Fórmula) en donde: Y1 e Y2 son independientemente O o S, y por lo menos uno de Y1 e Y2 es O; R1 y R2 son independientemente hidrógeno o un catión, ambos son hidrógeno o ambos son cationes; R3 es un alquilo que tiene de 1 a 4 átomos de carbono; R4 y R5 son independientemente halógeno o un alcóxido -OR6; R6 es arilo de 6 a 10 átomos de carbono unidos en la posición 5- o 6- del núcleo de bencimidazol.
MX2014014417A 2014-11-26 2014-11-26 Nuevos compuestos hidrosolubles derivados del bencimidazol, utiles para el tratamiento de la fasciolosis. MX365051B (es)

Priority Applications (7)

Application Number Priority Date Filing Date Title
MX2014014417A MX365051B (es) 2014-11-26 2014-11-26 Nuevos compuestos hidrosolubles derivados del bencimidazol, utiles para el tratamiento de la fasciolosis.
PE2017000898A PE20171112A1 (es) 2014-11-26 2015-11-25 Nuevos compuestos hidrosolubles derivados del bencimidazol, utiles para el tratamiento de la fasciolosis
PCT/MX2015/000154 WO2016085319A1 (es) 2014-11-26 2015-11-25 Nuevos compuestos hidrosolubles derivados del bencimidazol, utiles para el tratamiento de la fasciolosis
US15/529,218 US10239842B2 (en) 2014-11-26 2015-11-25 Hydrosoluble compounds derived from benzimidazole used in treating fasciolosis
BR112017010938-7A BR112017010938B1 (pt) 2014-11-26 2015-11-25 Compostos hidrossolúveis derivados do benzimidazol, composição farmacêutica e uso da composição farmacêutica
CL2017001320A CL2017001320A1 (es) 2014-11-26 2017-05-23 Nuevos compuestos hidrosolubles derivados del bencimidazol,
CONC2017/0005118A CO2017005118A2 (es) 2014-11-26 2017-05-23 Nuevos compuestos hidrosolubles derivados del bencimidazol, utiles para el tratamiento de la fasciolosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2014014417A MX365051B (es) 2014-11-26 2014-11-26 Nuevos compuestos hidrosolubles derivados del bencimidazol, utiles para el tratamiento de la fasciolosis.

Publications (2)

Publication Number Publication Date
MX2014014417A MX2014014417A (es) 2016-05-26
MX365051B true MX365051B (es) 2019-05-09

Family

ID=56074744

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014014417A MX365051B (es) 2014-11-26 2014-11-26 Nuevos compuestos hidrosolubles derivados del bencimidazol, utiles para el tratamiento de la fasciolosis.

Country Status (7)

Country Link
US (1) US10239842B2 (es)
BR (1) BR112017010938B1 (es)
CL (1) CL2017001320A1 (es)
CO (1) CO2017005118A2 (es)
MX (1) MX365051B (es)
PE (1) PE20171112A1 (es)
WO (1) WO2016085319A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108003188A (zh) * 2017-12-25 2018-05-08 长春吉大天元化学技术股份有限公司 一种烷基磷酸酯类化合物的新型纯化方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9103776D0 (sv) * 1991-12-19 1991-12-19 Astra Ab New compounds
TW200740838A (en) 2005-07-28 2007-11-01 Intervet Int Bv Novel benzimidazole (thio)carbamates with antiparasitic activity and the synthesis thereof

Also Published As

Publication number Publication date
CO2017005118A2 (es) 2017-09-20
US20170327470A1 (en) 2017-11-16
MX2014014417A (es) 2016-05-26
BR112017010938A2 (pt) 2018-07-03
PE20171112A1 (es) 2017-08-07
US10239842B2 (en) 2019-03-26
BR112017010938B1 (pt) 2022-08-16
CL2017001320A1 (es) 2017-12-29
WO2016085319A1 (es) 2016-06-02

Similar Documents

Publication Publication Date Title
MX2016014238A (es) Composicion limpiadora.
MA40301B1 (fr) Composés indolecarboxamides utiles comme inhibiteurs de kinase
TR201900038T4 (tr) GPR6'nın tetrahidropiridopirazin modülatörleri.
MX2017003930A (es) Derivados de aminotriazina utiles como compuestos inhibidores de la cinasa de union a tank.
BR112017003898A2 (pt) análogos de dioxolano de uridina para o tratamento de câncer
AR099138A1 (es) Piridinas fusionadas como inhibidores del complejo p97
MX2018016290A (es) Agente antidesgaste.
MX2019004569A (es) Metodo para producir 3-alquilsulfanil-2-cloro-n-(1-alquil-1h-tetra zol-5-il)-4-trifluorometilbenzamidas.
MX2018005133A (es) Intermediarios para preparar herbicidas de piridazinona y proceso para prepararlos.
CR20160198A (es) Derivados de etinilo-imidazolidín-2, 4-diona como moduladore mglur4
PH12019550224A1 (en) Antitumoral compounds
MX2017014661A (es) Proceso para la preparacion de triazinas.
AR109689A1 (es) Compuesto de oxadiazol y su uso
MX2016014240A (es) Composicion limpiadora.
MY172176A (en) Alkyl trityl phenyl ethers
PH12016501343B1 (en) Emulsion composition for skin
PH12016501613A1 (en) Pyrazines modulators of gpr6
PH12016500144A1 (en) Imidazothia(dia)zole sulfonamides as nematicides
MX369345B (es) Procesos para la preparacion de analogos de oxitocina.
MX2016001641A (es) Ciclobutilcarboxamidas como nematicidas.
BR112016021910A2 (pt) Processo de preparação de 3-(3-(4-(1-aminociclobutil)fenil)-5-fenil-3h-imidazo[4,5-b]piridin-2-il)piridin-2-amina
MX2019002017A (es) Derivados de sofosbuvir para el tratamiento de la hepatitis c.
MX2014014417A (es) Nuevos compuestos hidrosolubles derivados del bencimidazol, utiles para el tratamiento de la fasciolosis.
MX348867B (es) Compuestos quimicos.
MX2016016917A (es) Agente fluoroalquilante.

Legal Events

Date Code Title Description
FG Grant or registration